Inventor · disambiguated record
Curtis A. Spilburg
Also filed as: SPILBURG CURTIS A
20 granted patents·10 pending applications·346 citations·filing 1979–2014
95Inventor score
Top patents by PatentIndex Score
30 records- 0194US4687841APeptide hydroxamic acid derivativesMONSANTO CO·Filed 1985·Granted Aug 18, 1987·71 cites·3 claims
- 0293US4720486AMethod of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivativesMONSANTO CO·Filed 1987·Granted Jan 19, 1988·69 cites·4 claims
- 0379US5063210AUse of sulfated polysaccharides to decrease cholesterol and fatty acid absorptionLANGE III LOUIS G·Filed 1989·Granted Nov 5, 1991·54 cites·4 claims
- 0471US7071174B1Method and composition for inhibiting cholesterol esteraseCV THERAPEUTICS INC·Filed 2000·Granted Jul 4, 2006·2 cites·6 claims
- 0567US2008124387A1Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrientsKAPAC LLC·Filed 2006·Application pending·0 cites
- 0666US2015031628A1Methods and formulations for converting intravenous and injectable drugs into oral dosage formsZOMANEX LLC·Filed 2014·Application pending·0 cites
- 0765US5484777APancreatic cholesterol esterase inhibitorFiled 1993·Granted Jan 16, 1996·22 cites·1 claims
- 0862US5017565AUse of sulfated polysaccharides to inhibit pancreatic cholesterol esteraseLANGE III LOUIS G·Filed 1989·Granted May 21, 1991·25 cites·2 claims
- 0962US4243582ANovel glycoproteins from bovine cartilageMONSANTO CO·Filed 1979·Granted Jan 6, 1981·19 cites·3 claims
- 1062US2015030671A1Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrientsZOMANEX LLC·Filed 2014·Application pending·0 cites
- 1161US2006093661A1Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugsKAPAC LLC·Filed 2005·Application pending·0 cites
- 1260US5173408AMammalian pancreatic cholesterol esteraseLANGE LOUIS GEORGE III·Filed 1989·Granted Dec 22, 1992·21 cites·3 claims
- 1360US4752578ACollagenase inducing factorMONSANTO CO·Filed 1986·Granted Jun 21, 1988·9 cites·3 claims
- 1460US2009088393A1Methods and formulations for converting intravenous and injectable drugs into oral dosage formsZOMANEX LLC·Filed 2007·Application pending·0 cites
- 1559US2005244488A1Methods and formulations for enhansing the absorption and gastro-intestinal bioavailability of hydrophobic drugsKAPAC LLC·Filed 2005·Application pending·0 cites
- 1657US9107825B2Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugsZOMANEX LLC·Filed 2012·Granted Aug 18, 2015·0 cites·20 claims
- 1756US5616570AUse of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtionFiled 1994·Granted Apr 1, 1997·19 cites·12 claims
- 1855US2003212046A1Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugsKAPAC LLC·Filed 2002·Application pending·0 cites
- 1952US2011111009A1Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrientsZOMANEX LLC·Filed 2011·Application pending·0 cites
- 2050US2004047946A1Methods and formulations useful for lowering the cholesterol content of egg yolkKAPAC LLC·Filed 2003·Application pending·0 cites
- 2149US5352601AMethod for recovering purified 52,000 dalton fraction of human pancreatic cholesterol esterase using deae-cellulose, hydroxyapatite and heparin-sepharoseLANGE III LOUIS G·Filed 1992·Granted Oct 4, 1994·9 cites·2 claims
- 2243US5624836ADNA encoding bovine pancreatic cholesterol esteraseFiled 1995·Granted Apr 29, 1997·6 cites·6 claims
- 2343US5492822AMethod for recovering purified 100,000 dalton molecular weight fraction of human pancreatic cholesterol esteraseLANGE III LOUIS G·Filed 1995·Granted Feb 20, 1996·4 cites·5 claims
- 2442US5981299AMammalian pancreatic cholesterol esteraseCV THERAPEUTICS INC·Filed 1998·Granted Nov 9, 1999·5 cites·2 claims
- 2542US5521303AMethod of manufacturing non-absorbable synthetic sulfated polysaccharidesCV THERAPEUTICS INC·Filed 1994·Granted May 28, 1996·4 cites·11 claims
- 2641US2005153948A1Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosteroneZOMANEX LLC·Filed 2004·Application pending·0 cites
- 2733US6632801B1Method and composition for inhibiting human cholesterol esteraseCV THERAPEUTICS INC·Filed 1997·Granted Oct 14, 2003·1 cites·16 claims
- 2833US5679375AMethod of treating ulcers with sulfated polysaccharidesC V THERAPEUCTICS·Filed 1995·Granted Oct 21, 1997·4 cites·3 claims
- 2930US5429937AMethod for recovering purified 100,000 molecular weight fraction of human pancreatic cholesterol esterase using heparin agaroseCV THERAPEUTICS·Filed 1994·Granted Jul 4, 1995·2 cites·1 claims
- 3029US5792832APeptides from mammalian pancreatic cholesterol esteraseFiled 1995·Granted Aug 11, 1998·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →